Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Catherine C Park
Affiliation
University of California san francisco
ORCID
Career Start Year
2000
Papers
53
H Index
30
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37335545
Modifiable Postmastectomy Radiation Therapy Factors and Impact on Implant-Based Breast Reconstruction Outcomes.
Plast Reconstr Surg
2024
37478956
American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics.
Int J Radiat Oncol Biol Phys
2024
37143943
Dosimetric characterization of single- and dual-port temporary tissue expanders for postmastectomy radiotherapy using Monte Carlo methods.
Front Oncol
2023
34550601
Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data.
Cancer
2022
35688516
Seminars in Radiation Oncology-Breast Cancer.
Semin Radiat Oncol
2022
35777389
Contralateral Disease Begets Contralateral Treatment.
Int J Radiat Oncol Biol Phys
2022
34153380
Residents-as-Teachers Curriculum for Radiation Oncology: A Targeted Needs Assessment.
Int J Radiat Oncol Biol Phys
2021
28830795
Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
Clin Breast Cancer
2018
30190786
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction.
Oncotarget
2018
29126306
The Future of Radiobiology.
J Natl Cancer Inst
2018
29296631
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.
J Med Imaging (Bellingham)
2018
28973887
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Proc Natl Acad Sci U S A
2017
26714943
Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
Ann Surg Oncol
2016
26335703
Dosimetric Comparison Between 3-Dimensional Conformal and Robotic SBRT Treatment Plans for Accelerated Partial Breast Radiotherapy.
Technol Cancer Res Treat
2016
26860947
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.
Breast Cancer Res Treat
2016
25716473
TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.
Cancer Immunol Res
2015
26337386
Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors.
Mol Biol Cell
2015
26089220
ACR Appropriateness Criteria® Ductal Carcinoma in Situ.
Oncology (Williston Park)
2015
25959051
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
Integr Biol (Camb)
2015
25936815
Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy.
Int J Radiat Oncol Biol Phys
2015
24246724
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.
Int J Radiat Oncol Biol Phys
2014
25457912
Postmastectomy radiotherapy in patients with breast cancer.
Lancet
2014
25375000
The current clinical value of the DCIS Score.
Oncology (Williston Park)
2014
24584875
Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
Breast Cancer Res Treat
2014
24701707
ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.
Oncology (Williston Park)
2014
24292868
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.
Breast Cancer Res Treat
2014
23576567
NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.
Cancer Res
2013
23883667
β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.
Breast Cancer Res
2013
23667451
MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.
PLoS One
2013
23644530
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.
Cancer Res
2013
23812769
Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.
Ann Surg Oncol
2013
23407655
Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures.
Integr Biol (Camb)
2013
22929235
Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure.
Plast Reconstr Surg
2012
21416100
Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI.
Integr Biol (Camb)
2011
21884573
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
Breast Cancer Res
2011
19395189
Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation.
Int J Radiat Oncol Biol Phys
2010
20516121
Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.
Cancer Res
2010
20206016
American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.
Int J Radiat Oncol Biol Phys
2010
19701706
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.
Breast Cancer Res Treat
2010
18692323
High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.
Int J Radiat Oncol Biol Phys
2009
19895268
beta1 integrin targeting to enhance radiation therapy.
Int J Radiat Biol
2009
18519702
Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
Cancer Res
2008
18492917
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
AJR Am J Roentgenol
2008
17234776
Increased beta1 integrin is associated with decreased survival in invasive breast cancer.
Cancer Res
2007
18058364
beta1 integrin as a molecular therapeutic target.
Int J Radiat Biol
2007
16452209
Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.
Cancer Res
2006
15667984
A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment.
Int J Radiat Oncol Biol Phys
2005
16327765
Radiation and the microenvironment - tumorigenesis and therapy.
Nat Rev Cancer
2005
15647075
Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment.
Breast J
2005
12960393
Ionizing radiation induces heritable disruption of epithelial cell interactions.
Proc Natl Acad Sci U S A
2003
1 - 50 of 53
Column Actions
Search
Recommended Authors
Collin L Kent
Duke University Medical Center
Career Start Year
2011
Number of shared co-authors
0
Simona F Shaitelman
University of Texas MD Anderson Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Carmen Criscitiello
University of Milano
Career Start Year
2008
Number of shared co-authors
1
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
1
Shayna L Showalter
University of Virginia School of Medicine
Career Start Year
2007
Number of shared co-authors
0
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year
2006
Number of shared co-authors
1
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year
2004
Number of shared co-authors
1
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Tanya L Hoskin
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year
2003
Number of shared co-authors
3
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year
2002
Number of shared co-authors
0
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
0
Judy C Boughey
Mayo Clinic
Career Start Year
2001
Number of shared co-authors
5
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
1
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year
1998
Number of shared co-authors
5
Isabel T Rubio
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year
1998
Number of shared co-authors
4
Sarah L Blair
University of California
Career Start Year
1996
Number of shared co-authors
1
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year
1995
Number of shared co-authors
0
Steven J Isakoff
Massachusetts General Hospital
Career Start Year
1995
Number of shared co-authors
3
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year
1995
Number of shared co-authors
2
Peter Bult
Radboud University Medical Center
Career Start Year
1994
Number of shared co-authors
1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
2
Wey L Leong
University Health Network
Career Start Year
1992
Number of shared co-authors
0
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year
1990
Number of shared co-authors
2
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year
1988
Number of shared co-authors
1
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year
1986
Number of shared co-authors
0
Eric P Winer
Dana-Farber Cancer Institute
Career Start Year
1985
Number of shared co-authors
4
David R McCready
University of Toronto, University Health Network
Career Start Year
1984
Number of shared co-authors
1
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year
1981
Number of shared co-authors
2
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Career Start Year
1976
Number of shared co-authors
3
Larry Norton
Memorial Sloan Kettering Cancer Center
Career Start Year
1976
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Joe W Gray
Oregon Health and Science University
Co-authored papers
3
Adam B Olshen
12224University of California san francisco
Co-authored papers
3
Arman Jahangiri
Hamadan University of Medical Sciences
Co-authored papers
2
Sylvain V Costes
NASA Ames Research Center
Co-authored papers
2
Steve E Braunstein
University of California san francisco
Co-authored papers
2
Valerie M Weaver
University of California san francisco
Co-authored papers
2
Robert G Bristow
University of Toronto
Co-authored papers
2
Manish K Aghi
University of California san francisco
Co-authored papers
2
Michael De Lay
University of California San Francisco (UCSF)
Co-authored papers
2
Lauren Boreta
Co-authored papers
2
Patrick Y Wen
Co-authored papers
1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
1
Susan G Hilsenbeck
Co-authored papers
1
Peter M Black
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers
1
Daphne A Haas-Kogan
Co-authored papers
1
Patrick M Flanigan
Mayo Clinic
Co-authored papers
1
David N Louis
Co-authored papers
1
William A Weiss
University of California san francisco
Co-authored papers
1
Ankush Chandra
University of California san francisco
Co-authored papers
1
Gabriele Bergers
VIB-Center for Cancer Biology
Co-authored papers
1
Denise M Wolf
University of California San Francisco
Co-authored papers
1
Michael L Steinberg
University of California los angeles
Co-authored papers
1
Jessica D Tenenbaum
Duke University
Co-authored papers
1
Alan T Nguyen
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers
1
Maxim Sidorov
California Pacific Medical Center Research Institute
Co-authored papers
1
Brandon S Imber
University of California at San Francisco
Co-authored papers
1
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers
1
Sandra Demaria
Weill Cornell Medical College
Co-authored papers
1
Charles Kent Osborne
Co-authored papers
1
Joanne B Weidhaas
University of California-Los Angeles
Co-authored papers
1
1 - 30